Insights

U.S. States Navigate Psychedelics Reforms Amidst Legalization Efforts

As the United States continues to explore the boundaries of drug policy reform, numerous state legislatures and advocacy groups are engaging in a concerted effort to redefine the legal status of psychedelics. From decriminalization and legalization to the establishment of new research agencies, the landscape of psychedelics law is shifting, albeit with nuanced public support. ...

November 6th, 2023|

Alabama Medical Cannabis Commission Sets December Goal for Licensing Amid Legal Challenges

Alabama — After navigating through a series of legal hurdles and procedural delays, the Alabama Medical Cannabis Commission (AMCC) is now targeting December to finalize industry licenses, a move that its chairman describes as part of an "aggressive" timeline. This latest development comes as the commission attempts to recover from a summer marked by regulatory ...

November 5th, 2023|

Kansas City Cannabis Workers Vote to Unionize, Joining Teamsters Local 955

LOS ANGELES— Employees at Home State Dispensary in Kansas City have made a landmark decision to unionize, becoming the first group of cannabis workers in the metro area to do so. The budtenders and inventory clerks have elected to join Teamsters Local 955, marking a significant moment for labor relations within Missouri's burgeoning cannabis industry. ...

November 5th, 2023|

MindMed Projects Operational Continuity into 2026 Amid Advancements in LSD-Based Anxiety Treatment

NEW YORK — Mind Medicine Inc. (MindMed), a biopharmaceutical company leading the charge in psychedelic drug development, has assured stakeholders of its financial viability well into 2026. This assurance comes even as the company, which currently does not generate revenue, moves closer to the potential market introduction of its proprietary LSD formulation intended for anxiety treatment. ...

November 5th, 2023|

Psyence Group Advances Psilocybin Production with Facility Expansion and Strategic Partnerships

LOS ANGELES- Psyence Group Inc.  a trailblazer in the clinical-stage life sciences sector specializing in nature-derived psilocybin for mental health treatments, has announced significant developments in its Psyence Production division. The company takes pride in operating one of the pioneering government-licensed commercial psilocybin cultivation facilities, located in Southern Africa and ISO22000 certified, which positions Psyence ...

November 3rd, 2023|

U.S. Cannabis Operators Challenge Federal Enforcement in Landmark Lawsuit

LOS ANGELES- In a bold move that underscores the growing tension between state legislation and federal restrictions, a coalition of U.S. cannabis operators and investors has filed a lawsuit challenging the federal government's application of the Controlled Substances Act (CSA) to cannabis. The suit claims that the federal prohibition of cannabis stands in stark conflict ...

November 3rd, 2023|

Navigating Cannabis Conferences: A Comprehensive Guide for Companies

LOS ANGELES--If your company is gearing up to attend a cannabis conference, it's crucial to approach it with a well-thought-out strategy. The earlier you start your preparations, the better the results you can expect. My team and I started this SOP for MJBizCon, and I wanted to share it with any other teams planning to ...

November 3rd, 2023|

Arizona Social Equity Cannabis License Holders Face Deadline Challenges

PHOENIX — As the state-mandated deadline of Sunday, Oct. 8, looms, more than half of Arizona’s social equity cannabis retail licensees risk missing the critical opening date for their businesses. Of the 26 license holders, 14 are behind schedule, which could potentially lead to penalties including the revocation of their licenses. Despite this, the Arizona ...

November 3rd, 2023|
  • Ayr Wellness Announces Brand Launches in Massachusetts and Ohio

Economic Report Foresees Financial Upside for Ohio in Legalizing Recreational Cannabis

LOS ANGELES — A recent economic assessment suggests that Ohio could reap significant financial benefits should voters opt to legalize recreational cannabis use. As reported by the Ohio Capital Journal, analysis from the Columbus-based Scioto Analysis indicates an annual net benefit of approximately $260 million if Issue 2 is approved in the upcoming November 7 ...

November 3rd, 2023|

Kanabo Partners with British Cannabis to Enhance Digital Health Services

LOS ANGELES- In a significant move to provide enhanced digital health services and specialty medicines, including medicinal cannabis, Kanabo (KNB), a patient-centric provider, has announced a collaborative partnership with British Cannabis. This collaboration will facilitate the availability of pharmacy-grade CBD health supplements to patients. Starting soon, British Cannabis's CBD products will be procurable through prescriptions ...

November 2nd, 2023|

Cybin Inc. Releases Interim Findings for Its Innovative Psilocybin Analog, CYB003

LOS ANGELES- In a major step for mental health treatment innovation, Cybin Inc. today publicized the interim results of its Phase 2 clinical trial for CYB003, its proprietary deuterated psilocybin analog. These findings highlight a robust and statistically substantial decrease in depressive symptoms as early as three weeks post a single 12mg dosage, a remarkable ...

November 2nd, 2023|

Virginia Judge Upholds State Law on Hemp Products in Notable Ruling

LOS ANGELES- In a notable legal decision, a federal judge in Northern Virginia declined to halt the enforcement of a recently established state law imposing stricter controls on hemp-derived products, as reported by the Virginia Mercury on Monday. The law, which tightens the regulations on products containing delta-8 THC, was defended by U.S. District Judge ...

November 1st, 2023|

Colorado Awards First Loans to Social Equity Cannabis Businesses

DENVER — In a move that underlines the state's commitment to fostering equitable growth in the cannabis industry, Colorado's Cannabis Business Office (CBO) has unveiled the inaugural recipients of the state's Cannabis Business Loan Program. Launched in collaboration with the mission-oriented lender, NuProject, this initiative facilitates loans ranging from $50,000 to $150,000. The program is ...

November 1st, 2023|

Massachusetts Cannabis Companies Challenge Federal Prohibition in Lawsuit Against U.S. Attorney General

LOS ANGELES- A coalition of Massachusetts-based cannabis businesses has initiated legal proceedings against U.S. Attorney General Merrick Garland, presenting a strong case against the current federal cannabis prohibition. The litigants argue that the said prohibition is not only unconstitutional but also unduly infringes on state rights, thereby placing their businesses in jeopardy by compelling them ...

October 30th, 2023|

Washington State Suspends True Northwest Lab’s Quality Assurance Certification

WASHINGTON STATE — State regulators announced a suspension on the quality-assurance certification of the Olympia-based testing lab, True Northwest, after multiple concerns arose regarding the lab's testing reliability and operational procedures. In an official statement, the Washington State Liquor and Cannabis Board (LCB) mentioned, “The lab did not provide an acceptable corrective action report following ...

October 26th, 2023|

Cannabis and the Workplace: A Changing Paradigm

LOS ANGELES- In a recent survey, compelling insights were unveiled concerning the changing attitudes and behaviors of individuals towards cannabis consumption, emphasizing its medicinal applications and subsequent implications in the professional arena. Key Insights: Usage Dynamics: Among participants, 18% disclosed having used cannabis for therapeutic objectives in the past year, with 19% using it for ...

October 26th, 2023|

Debunking Fentanyl and Cannabis Misconceptions

NEW YORK- The New York Office of Cannabis Management (OCM) has released a comprehensive report addressing the widespread misinformation suggesting that cannabis is being contaminated with fentanyl. This misinformation has been perpetuated through various channels, from law enforcement narratives to political leaders. The report titled “Cannabis and Fentanyl: Facts and Unknowns” aims to separate fact ...

October 26th, 2023|

Oregon Cannabis Associations Merge Amidst Industry Challenges

LOS ANGELES- In a significant development within Oregon's cannabis sector, the Oregon Cannabis Association and the Cannabis Industry Alliance of Oregon have decided to merge. The boards of both organizations approved this union last week, as reported by Oregon Public Broadcasting. The newly formed entity, named the Cannabis Industry Alliance of Oregon, will represent a ...

October 25th, 2023|

Beckley Psytech Begins Landmark Phase IIb Study on Novel Intranasal 5-MeO-DMT Formulation for Treatment Resistant Depression

LOS ANGELES- In a significant development for the field of neuropsychiatric treatment, Beckley Psytech Ltd, a leading clinical-stage biotechnology firm, announced today the initiation of its international Phase IIb study on BPL-003. This novel synthetic intranasal formulation of 5-MeO-DMT is being tested for its potential in treating Treatment Resistant Depression (TRD). The study, a multi-centre ...

October 25th, 2023|

The Rise and Debate of Delta-8 THC: Understanding the Controversy

LOS ANGELES- Delta-8-Tetrahydrocannabinol (delta-8 or ∆8-THC) is making headlines as its popularity soars, primarily due to federal regulations that ambiguously classify it. Resembling the more commonly known Delta-9-Tetrahydrocannabinol in structure and effect, this lesser-known cannabinoid is now under the microscope for its origins, safety, and place in the industry. Historical Perspective Delta-8 was first partially ...

October 24th, 2023|

Aurora Cannabis Settles Patent Litigation with Willow Biosciences

TORONTO — Aurora Cannabis, the Alberta-based licensed producer, has finalized a confidential settlement with Willow Biosciences over a previously ongoing patent litigation that began in July 2021. The specific terms and conditions of the settlement remain under wraps, with both companies refraining from public disclosure of detailed particulars. Aurora had previously initiated the patent infringement ...

October 24th, 2023|

FSD Pharma and Celly Nutrition Corp. Schedule Virtual Securityholders Meeting

TORONTO — FSD Pharma, a noted biopharmaceutical company, and its partner Celly Nutrition Corp. have jointly announced a virtual meeting for FSD Pharma's securityholders. Slated for November 20, 2023, at 1:00 p.m. Toronto time, this virtual gathering will take place via the AGM Connect platform. The main objective of this assembly is to approve the ...

October 23rd, 2023|

House VA Subcommittee Postpones Historic Psychedelic-Assisted Therapy Hearing

LOS ANGELES- A groundbreaking hearing of the House VA’s subcommittee on Health, set to discuss the potential of psychedelic-assisted therapies in combating mental health disorders, has been postponed. The delay was attributed to the ongoing turmoil in the House over the election of a new speaker. The aptly named "Emerging Therapies: Breakthroughs in the Battle ...

October 23rd, 2023|
Go to Top